These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37413872)

  • 21. Concordance of Mini-Mental State Examination, Montreal Cognitive Assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease.
    Scheffels JF; Fröhlich L; Kalbe E; Kessler J
    J Neurol Sci; 2020 May; 412():116735. PubMed ID: 32087430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of cognitive reserve with motor and cognitive functions for different stages of Parkinson's disease.
    Guzzetti S; Mancini F; Caporali A; Manfredi L; Daini R
    Exp Gerontol; 2019 Jan; 115():79-87. PubMed ID: 30502539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.
    Nazem S; Siderowf AD; Duda JE; Have TT; Colcher A; Horn SS; Moberg PJ; Wilkinson JR; Hurtig HI; Stern MB; Weintraub D
    J Am Geriatr Soc; 2009 Feb; 57(2):304-8. PubMed ID: 19170786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid Eye Movement Sleep Behavior Disorder Symptoms Correlate with Domains of Cognitive Impairment in Parkinson's Disease.
    Zhang JR; Chen J; Yang ZJ; Zhang HJ; Fu YT; Shen Y; He PC; Mao CJ; Liu CF
    Chin Med J (Engl); 2016 Feb; 129(4):379-85. PubMed ID: 26879009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olfaction and taste in Parkinson's disease: the association with mild cognitive impairment and the single cognitive domain dysfunction.
    Cecchini MP; Federico A; Zanini A; Mantovani E; Masala C; Tinazzi M; Tamburin S
    J Neural Transm (Vienna); 2019 May; 126(5):585-595. PubMed ID: 30911822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease.
    Jones JD; Burroughs M; Apodaca M; Bunch J
    Neuropsychology; 2020 Jan; 34(1):24-30. PubMed ID: 31219297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the sensitivity and specificity of cognitive screening measures for people with Parkinson's disease.
    Foley T; McKinlay A; Warren N; Stolwyk RJ
    NeuroRehabilitation; 2018; 43(4):491-500. PubMed ID: 30400110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment in Parkinson's disease.
    Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; Middelkoop HA; van Hilten JJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1182-7. PubMed ID: 17442759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease.
    Gjerde KV; Müller B; Skeie GO; Assmus J; Alves G; Tysnes OB
    Acta Neurol Scand; 2018 Dec; 138(6):508-514. PubMed ID: 30058142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment is common in Parkinson's disease without dementia in the early and middle stages in a Han Chinese cohort.
    Wu Q; Chen L; Zheng Y; Zhang C; Huang L; Guo W; Fang Y; Zhou H; Liu Y; Chen J; Qian H; Xian W; Zeng J; Li J; Liu Z; Pei Z
    Parkinsonism Relat Disord; 2012 Feb; 18(2):161-5. PubMed ID: 21975261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olfactory impairment predicts cognitive decline in early Parkinson's disease.
    Fullard ME; Tran B; Xie SX; Toledo JB; Scordia C; Linder C; Purri R; Weintraub D; Duda JE; Chahine LM; Morley JF
    Parkinsonism Relat Disord; 2016 Apr; 25():45-51. PubMed ID: 26923521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.
    Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I
    J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease.
    Sousa NMF; Brucki SMD
    Arq Neuropsiquiatr; 2023 Feb; 81(2):155-163. PubMed ID: 36863401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric Symptoms and Cognitive Impairment in Chinese Patients with Parkinson's Disease in Han and Hui Ethnicity.
    Yao ML; Zhang H; Xu Y; Zhang SM; Gao YZ; Shu M; Zhang JJ
    Curr Med Sci; 2019 Feb; 39(1):122-126. PubMed ID: 30868501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
    Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
    J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.